GE to debut new mini cyclotron
GE Medical Systems will introduce a new cyclotron at next month’s Society of Nuclear Medicine meeting in Los Angeles that is targeted to produce radiopharmaceuticals for individual PET sites. The new cyclotron is called MINItrace and is a smaller
GE Medical Systems will introduce a new cyclotron at next months Society of Nuclear Medicine meeting in Los Angeles that is targeted to produce radiopharmaceuticals for individual PET sites. The new cyclotron is called MINItrace and is a smaller version of the Milwaukee vendors PETtrace system, which is more expensive but has a higher output that can support multiple PET sites, according to David Hollnagel, director of Americas marketing for GEs nuclear medicine division.
In addition to MINItrace, GE will also emphasize cardiology and oncology applications for its line of SPECT and PET cameras. On the cardiology side, the company will feature products from GE Marquette that are used in nuclear stress tests, such as treadmills and monitoring devices. GE bought Marquette last year (SCAN 9/30/98).
On the workstation side, GE will demonstrate its Genie workstations running on a new Intel Xeon 450 MHz processor. The company will also show the Expert workstation developed by Elscints nuclear medicine division, which GE acquired in November (SCAN 12/16/98). The integration of Elscint employees and products has gone well, Hollnagel said.
GE also plans to introduce a major new technology development at the SNM, but declined to provide details before the conference. The technology is the product of the companys nuclear medicine R&D relationship with ELGEMS of Israel, Hollnagel said.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
